Skip to main content
VCbacked
Log inGet Started

Nivagen Pharmaceuticals

Sacramento, United States

Nivagen Pharmaceuticals engages in the development, acquisition, and sales of generic prescription drugs and over the counter products.

$5.0M raised
Aug 2023
Venture - Series Unknown
ManufacturingMarket ResearchPharmaceutical

Top Investors

Telegraph Hill Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nivagen Pharmaceuticals

How much funding has Nivagen Pharmaceuticals raised?
Nivagen Pharmaceuticals has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2023.
Who are Nivagen Pharmaceuticals's investors?
Nivagen Pharmaceuticals's investors include Telegraph Hill Partners.
Where is Nivagen Pharmaceuticals headquartered?
Nivagen Pharmaceuticals is headquartered in Sacramento, United States.
What does Nivagen Pharmaceuticals do?
Nivagen Pharmaceuticals engages in the development, acquisition, and sales of generic prescription drugs and over the counter products.
What stage is Nivagen Pharmaceuticals at?
Nivagen Pharmaceuticals is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Nivagen Pharmaceuticals — Funding & Investors." VCBacked, August 9, 2023, https://www.vcbacked.co/company/nivagen-pharmaceuticals. Accessed June 13, 2026.
APA
VCBacked. (2023). Nivagen Pharmaceuticals — Funding & Investors. Retrieved June 13, 2026, from https://www.vcbacked.co/company/nivagen-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Nivagen Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/nivagen-pharmaceuticals |website=VCBacked |access-date=June 13, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Manufacturing

View all
Quinas Technology
Lancaster$30K
SWEBAL
Stockholm$3.5M
Aplantex
Montréal$2.1M
Xometry
Gaithersburg
Nyobolt
Cambridge$30.0M
Trillium Renewable Chemicals
Knoxville